Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002925
Filing Date
2008-03-17
Accepted
2008-03-17 15:44:36
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183611z10-k.htm 10-K 935833
2 EXHIBIT 4.12 a2183611zex-4_12.htm EX-4.12 55729
3 EXHIBIT 10.32 a2183611zex-10_32.htm EX-10.32 43003
4 EXHIBIT 10.33 a2183611zex-10_33.htm EX-10.33 88221
5 EXHIBIT 10.34 a2183611zex-10_34.htm EX-10.34 196172
6 EXHIBIT 23.1 a2183611zex-23_1.htm EX-23.1 3468
7 EXHIBIT 31.1 a2183611zex-31_1.htm EX-31.1 7750
8 EXHIBIT 31.2 a2183611zex-31_2.htm EX-31.2 7728
9 EXHIBIT 32 a2183611zex-32.htm EX-32 7114
10 G42344.JPG g42344.jpg GRAPHIC 11296
11 G866042.JPG g866042.jpg GRAPHIC 11405
  Complete submission text file 0001047469-08-002925.txt   1377819
Mailing Address
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
METABASIS THERAPEUTICS INC (Filer) CIK: 0001053221 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50785 | Film No.: 08692854
SIC: 2834 Pharmaceutical Preparations